Dacotin 50 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Dacotin 50 Injection
Oncocin 50 Injection treats colorectal cancer by inhibiting or reducing cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's prescription; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, tiredness, vomiting, and diarrhea. The medication can decrease blood cell counts (red and white), raising infection risk. Serious allergic reactions, such as mouth sores, rash, itching, and respiratory distress, require immediate medical attention. Regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid are necessary. Inform your doctor of pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications. Interactions with other drugs are possible; disclose all medications to your healthcare provider. Use during pregnancy or breastfeeding is contraindicated. Male infertility is a potential side effect; sperm preservation should be discussed with your doctor prior to treatment. Avoid driving due to potential dizziness.
Uses of Dacotin 50 Injection
Colorectal cancer
Major Benefits of Dacotin 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Dacotin 50 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Dacotin 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Dacotin 50 Injection works:
Oncocin 50 Injection is a cancer treatment agent that disrupts the genetic structure (DNA and RNA) of malignant cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Dacotin 50 Injection is undetermined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Dacotin 50 Injection during pregnancy is contraindicated due to confirmed risk to the fetus. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Dacotin 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
Administering Dacotin 50 Injection might induce adverse reactions impacting driving capabilities. Oxaliplatin therapy similarly elevates the likelihood of dizziness, nausea, vomiting, and other neurological issues impairing ambulation, potentially affecting driving ability.
KidneyCAUTION
Caution is advised when administering Dacotin 50 Injection to individuals with significant renal impairment; dosage modification may be necessary. Medical advice is recommended. Data regarding Dacotin 50 Injection use in such patients is limited. Dosage alterations are not suggested for those with mild or moderate kidney disease.
LiverCAUTION
For individuals with hepatic impairment, administration of Dacotin 50 Injection requires careful consideration. Dosage modification of Dacotin 50 Injection might be necessary. Physician consultation is advised.
What if you forget to take Dacotin 50 Injection :
Should you forget a scheduled Dacotin 50 Injection, seek medical advice.
Facts to Know About Dacotin 50 Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | Platinum-based Anticancer Agents |
3,018 People bought this recently